Newsletter | 01 February 2002 Access News 6, Focus on Malaria, February 2002 HIV/AIDS INTELLECTUAL PROPERTY AND TRADE MALARIA TROPICAL & NEGLECTED DISEASES VACCINES How much for an effective malaria treatment is the focus of this edition, as well as MSF in Burundi, Doha and a potential breakthrough, trapped in the ACCESS crisis, life with chagas and HIV and meningitis outbreaks. Read, watch, share Filter by - Any -BlogEventsFeature storyInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefVideo Events | 11 August 2006 HIV/AIDS Global Workshop Series- XVI Toronto AIDS Conference 2006 Newsletter | 01 August 2006 HIV/AIDS Access News 14, Focus on Toronto AIDS Conference, August 2006 Press release | 06 July 2006 HIV/AIDS Intellectual property and trade Abbott picks and chooses which patients get crucial new version of AIDS drug in developing countries Press release | 10 May 2006 HIV/AIDS Intellectual property and trade South AfricaIndia MSF supports opposition to Gilead's tenofovir patent application in India Press release | 27 April 2006 HIV/AIDS More empty promises: Abbott fails to supply critical new AIDS drug formulation to developing countries Press release | 30 March 2006 HIV/AIDS India Patent application for AIDS drug opposed for first time in India: MSF: Patents in India endanger global access to affordable medicines and treatment scale-up Press release | 28 March 2006 HIV/AIDS As WHO and UNAIDS call for global treatment scale-up, MSF asks: where will the essential drugs come from? Press release | 15 March 2006 HIV/AIDS Access denied to crucial new HIV/AIDS medicines Load More
Press release | 06 July 2006 HIV/AIDS Intellectual property and trade Abbott picks and chooses which patients get crucial new version of AIDS drug in developing countries
Press release | 10 May 2006 HIV/AIDS Intellectual property and trade South AfricaIndia MSF supports opposition to Gilead's tenofovir patent application in India
Press release | 27 April 2006 HIV/AIDS More empty promises: Abbott fails to supply critical new AIDS drug formulation to developing countries
Press release | 30 March 2006 HIV/AIDS India Patent application for AIDS drug opposed for first time in India: MSF: Patents in India endanger global access to affordable medicines and treatment scale-up
Press release | 28 March 2006 HIV/AIDS As WHO and UNAIDS call for global treatment scale-up, MSF asks: where will the essential drugs come from?
